Revenue (Tables)

3 Months Ended

Mar. 31, 2022

Revenue

Schedule of revenues disaggregated by Group, end customer geographical location and timing of recognition

The following table presents the Company’s revenues by Group and End Customer Geography (in millions):

	Three Months Ended March 31,
	2022			2021
Revenue by Group:
Bruker BioSpin	$	157.8		$	159.4
Bruker CALID		203.2			192.4
Bruker Nano		178.5			154.4
BEST		59.7			52.4
Eliminations		(4.2	)		(3.9	)
Total revenue	$	595.0		$	554.7
	Three Months Ended March 31,
	2022			2021
Revenue by End Customer Geography:
United States	$	155.0		$	119.0
Germany		58.5			70.1
Rest of Europe		143.4			149.8
China		86.3			66.8
Rest of Asia Pacific		102.6			113.7
Other		49.2			35.3
Total revenue	$	595.0		$	554.7

Revenue for the Company recognized at a point in time versus over time is as follows (in millions):

	Three Months Ended March 31,
	2022		2021
Revenue recognized at a point in time	$	514.0	$	480.0
Revenue recognized over time		81.0		74.7
Total revenue	$	595.0	$	554.7